CCM
EDIT icon

Coldstream Capital Management’s Editas Medicine EDIT Stock Holding History

Coldstream Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,582
Closed -$1.84K – 1751
2025
Q1 		$1.84K Buy
+1,582
New +$2.33K ﹤0.01% 3032

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Coldstream Capital Management's EDIT Position: Q2 2025 in Review

Coldstream Capital Management sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 1,582 shares — an estimated $1.84K sold.

Coldstream Capital Management first reported a position in EDIT in Q1 2025 and held it in 1 quarter. The position peaked at $1.84K in Q1 2025. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • Coldstream Capital Management reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 1,582 Editas Medicine shares in Q2 2025, an estimated $1.84K.
  • Coldstream Capital Management first reported a position in Editas Medicine in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Editas Medicine position peaked at $1.84K in Q1 2025.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.